Patents

US 8222259 B2: 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo[4,3-e]-1,2,4-triazolo[4,3-c]pyrimidin-3-one compounds for use as adenosine A2a receptor antagonists

Granted
2012-07-17
Filed
2009-03-03 application 12920924
Type
Utility · 21 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Compounds of the Formula I wherein R1 and R2 together with the carbon atoms to which they are bonded optionally form a further heteroaromatic ring of the formula (II) as well as pharmaceutically acceptable salts, solvates, esters and prodrugs thereof are adenosine A2a receptor antagonists and, therefore, are useful in the treatment of central nervous system diseases, in particular Parkinson's disease.

Source: PVGPATDIS, file of 2026-04-10 (ipg120717.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
SCHERING CORPORATION 216 patentsUS company or organizationRahway, NJSCHERING CORPORATION State business registration EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Joel M. HarrisKenilworth, NJ33PVGPATDIS, file of 2026-04-10
Bernard R. NeustadtKenilworth, NJ11PVGPATDIS, file of 2026-04-10
Jinsong HaoKenilworth, NJ8PVGPATDIS, file of 2026-04-10
Andrew StamfordKenilworth, NJ92PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07DHeterocyclic compoundsC07D487/14PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/00PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-08-08Merger
Merger
MERCK SHARP & DOHME CORP. signed 2022-04-07MERCK SHARP & DOHME LLC RAHWAY, NJ61102/145PASDL, file of 2026-10-15
2012-08-30Name change
Change of name
SCHERING CORPORATION signed 2012-05-02MERCK SHARP & DOHME CORP. RAHWAY, NJ28884/151PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.